📰 Accelerate Research News
Page 2 - Accelerate Research News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Accelerate Research. Real-time updates on events, politics, business and more.
May 26, 2023
Phoenix Childrens and the University of Arizona are partnering to accelerate pediatric research.
April 9, 2022
PathAI and GSK forms partnership today with a focus on accelerating research and- building drug development programs.
February 23, 2022
The nonprofit evaluator rated The Charcot-Marie-Tooth Association with a perfect 100 score and is the only CMT-related organization to be given four...
October 20, 2021
Friendly Community Walks to Advance Awareness & Accelerate Research for Myelodysplastic Syndromes - a Rare Blood CancerYARDVILLE, N.J., Oct. 20, 2021 (GLOBE NEWSWIRE) -- The MDS Foundation, a global non-profit
September 22, 2021
Ad Hoc Announcement Pursuant to Art. 53 LR Glenolden, PA and Geneva, Switzerland, September 22, 2021 (GLOBE NEWSWIRE) - The Charcot-Marie-Tooth Association (CMTA), the largest philanthropic funder
June 30, 2021
Theo đó, qua công tác giám sát trên không gian mạng, NCSC trực thuộc Cục này đã ghi nhận 4 điểm yếu, lỗ hổng bảo mật mới gồm CVE-2021-21571, CVE-2021-21572, CVE-2021-21573 và CVE-2021-21574 trong tính năng BIOS Connect và HTTPS Boot. Đây là tính năng, công cụ có sẵn trên hầu hết các máy tính, thiết bị của Dell để hỗ trợ việc cập nhật firmware và khôi phục hệ điều hành từ xa trên BIOS của các máy tí...
May 30, 2021
Bộ trưởng Bộ TT&TT vừa ban hành Chỉ thị 22 về tăng cường công tác phòng ngừa, chống vi phạm pháp luật và tội phạm trên mạng Internet. Trong đó, đặc biệt yêu cầu áp dụng công nghệ mới để phát hiện, cảnh báo, ngăn chặn hành vi tấn công mạng, đảm bảo hệ thống thông tin.
April 28, 2021
(0) Funding to Accelerate Hiring as Outcomes4Me Diversifies Cancer Support and Expands to Empower Patients in Europe CAMBRIDGE, Mass., April 28, 2021 /PRNewswire/ -- Outcomes4Me Inc., developer of an Artificial Intelligence (AI)-powered platform to empower cancer patients to navigate their care, today announced it has raised $12 million in an oversubscribed Series A round. Funds will be used to extend Outcomes4Mes platform beyond breast cancer to other cancers, grow the platforms regulatory-gra...
January 7, 2021
Press release content from PR Newswire. The AP news staff was not involved in its creation. VISEN Pharmaceuticals Receives IND Approval to Initiate Phase 2 Clinical Trial of TransCon ™ CNP in Achondroplasia (ACH) in China January 7, 2021 GMT SHANGHAI, Jan. 7, 2021 /PRNewswire/ -- VISEN Pharmaceuticals, a biotech company committed to the treatment of endocrine-related diseases, introducing the world’s leading treatment methods and drugs into the China market and hoping to provide more Chines...